NOTIFICATION OF THE REMOVAL FROM LISTING
AND REGISTRATION OF THE STATED SECURITIES

New York Stock Exchange LLC (the 'Exchange'
or the 'NYSE') hereby notifies the Securities
and Exchange Commission (the 'Commission')
of its intention to remove the entire class
of Common Stock of American Oriental
Bioengineering, Inc., (the 'Company') from
listing and registration on the Exchange at
the opening of business on June 25, 2012.
The decision to move to delist was reached
in view of the fact that the Company no longer
meets the standards for continued listing on
the NYSE in accordance with Section 802.01D of
the NYSE Listed Company Manual.

1. Pursuant to Section 802.01D of the Listed
Company Manual, a listed company is subject to
delisting when the company or its management
engages 'in operations which, in the opinion
of the Exchange, are contrary to the public
interest,' when the company fails to 'observe
good accounting practices in reporting of
earnings and financial position,' when the
company violates any of its listing agreements
with the Exchange or when the company engages
in '[o]ther conduct not in keeping with sound
public policy.'  The Company has triggered
application of these provisions based on the
following:

(a) On March 16, 2012, the Company announced
that its independent public accounting firm
noted certain 'inconsistencies' during the
course of its audit and that a special
investigation was being commenced by the
Company?s audit committee.

(b) On May 15, 2012, the Company filed a Form
8-K with the SEC reporting that the chairman
of its audit committee resigned on May 9, 2012
for health reasons.  The Company has provided
no further information regarding the reasons
for the resignation.  The audit committee
chairman's resignation during the independent
investigation the audit committee was conducting
into the inconsistencies identified by the
Company's independent public accounting firm
raises potential concerns.

(c) In violation of its listing agreement with
the NYSE and Section 802.01D of the Listed
Company Manual, the Company has failed to
provide all of the information reasonably
requested by NYSE Regulation within a
reasonable time frame and  has not responded
in writing to outstanding NYSE Regulation
requests for information.

(d) The Company has not publicly disclosed or
provided the Exchange with any reliable
up-to-date information about its current
financial results, operations or governance,
nor has it made the public disclosures regarding
material developments at the Company required by
Section 202.05 of the Listed Company Manual.
2. Additionally, Sections 303A.06 and 802.01D of
the Listed Company Manual require a listed company
to maintain an audit committee in conformity
with Rule 10A-3 under the Securities Exchange
Act of 1934 and NYSE standards, which require
each member of a listed company's audit committee
to be independent.  Prior to the audit committee
chairman's resignation, the Company's
representatives verbally advised the Exchange
that one of the other audit committee members
was in poor health.  The Company has not announced
the appointment of any other additional board
members.

3. Further, the Company did not bring its share
price and average share price above $1 by six
months following receipt of notice by the
Exchange that it had fallen below the NYSE's
$1 share price standard, as required by Section
802.01C of the Listed Company Manual.

4. The Company had also failed to timely file
its Form 10-K for the fiscal year ended
December 31, 2011 after the allowable SEC
extension period and is considered a late filer
under Section 802.01E of the NYSE Listed Company
Manual.

5.  The Exchange, on May 25, 2012, determined
that the Common Stock should be suspended from
trading immediately after the close of trading
session on May 25, 2012, and directed the
preparation and filing with the Commission of
this application for the removal of the Common
Stock from listing and registration on the
Exchange. The Company was notified of the
Exchange's delisting determination by letter
on May 25, 2012.

6.  Pursuant to the above authorization, a press
release was issued on May 25, 2012 and an
announcement was made on the 'ticker' of the
Exchange at the close of the trading session
on May 25, 2012 of the suspension of trading
in the Common Stock. Similar information was
included on the Exchange's website.  Trading
in the Common Stock in the Exchange was
suspended at the close of the trading session
on May 25, 2012.

7. The Company had a right to appeal to the
Committee for Review of the Board of Directors
of NYSE Regulation the determination to delist
its Common Stock, provided that it filed a
written request for such a review with the
Secretary of the Exchange within ten business
days of receiving notice of delisting
determination. The prescribed time for the
Company to file an appeal has expired and the
Company has not submitted an appeal request
within the prescribed time period. Accordingly,
the Exchange, having complied with all of its
procedures, is authorized to file this
application in accordance with Section 12 of
the Securities Exchange Act of 1934 and the
rules promulgated thereunder.